T2 Biosystems ( (TTOO) ) just unveiled an announcement.
T2 Biosystems has announced the successful defense of a crucial patent for its innovative blood pathogen detection method in the EU, bolstering its intellectual property portfolio. Despite opposition from bioMerieux and others, the European Patent Office backed T2 Biosystems’ patent, reinforcing the company’s strong position in direct-from-whole blood pathogen detection. This win is expected to enhance T2 Biosystems’ market leadership and support the advancement of its technology and product offerings.
Find detailed analytics on TTOO stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “Be the Leader You’ve Been Complaining For!” Paramount Stock (NASDAQ:PARA) Dips as Paramount Pulls Out of Politics
- Don’t “Get Rid of All Your Engine Designers”: Ford Stock (NYSE:F) Dips as it Brings Back a Big Name in Internal Combustion
- “Advanced Silicon Wafer Tests” Start; Intel Stock (NASDAQ:INTC) Slips